Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 December 2021 Photo Supplied
For Dr Katleho Tsilo, one of the latest graduates from the University of the Free State (UFS) Faculty of Health Sciences says graduating from medical school is a dream come true for her and her family.

For Dr Katleho Tsilo, one of the newest graduates from the University of the Free State (UFS) Faculty of Health Sciences, graduating from medical school does not only represent the answered prayers, persistence and sheer grace, it is also a dream come true for her and her family.

Dr Tsilo graduated on Monday 13 December 2021 during the UFS’ year-end graduating ceremonies. 

“It still feels unreal that I was able to overcome the greatest challenge that I was presented with. In my entire medical school career, I have faced many great challenges, from not having any kind of funding at all, to initially not being accepted into medicine to really having to fight for my position each and every semester while also fighting with and for my fellow students in the various leadership positions aforementioned. 

“There were moments of weakness where I wished to just quit it all, but with support from the faculty and my family, I managed to hold on. My dream was and still is bigger that any challenge that I have ever encountered,” says Dr Tsilo. 

Had various leadership positions

During her student years, this Botshabelo native engaged in various leadership positions. She also had to overcome numerous obstacles including the imposter syndrome. According to her, coming from a poor background, with very little resources, she sometimes felt insecure about what she could offer and what she is capable of. Being a health worker during the COVID-19 pandemic was also very challenging because of the uncertainty of everything and how dangerous the work environment in the hospital was proving to be.

“I was privileged enough to be elected as part of the MSA (Medical Students Association) in the Academics portfolio, this is where I then came up with the idea of collecting textbook donations and gifting the less privileged students. I was also elected to be part of the Residence Committee of the new Health Sciences Residence, in the Finance Portfolio.”

Can’t imagine doing anything else

Though she did not always want to study medicine, she ultimately decided on this field as she could not imagine doing anything else. She believes it is a calling, as she always wanted to live a life full of purpose and helping other people. Helping put a smile on someone’s face when they are going through illness is enough to change one’s life, explains Dr Tsilo about her decision to study medicine. She will be doing her internship at the Leratong Hospital in Krugersdorp, Gauteng.

Dr Tsilo, who is hoping to go into Health Science Education or Public Health, says her motivation comes from her family background. “Having been surrounded by poverty for the greater part of my life pushed me to become the difference. I was and still am determined to not be another statistic. Another thing that really motivates me is being of some help to someone. I cannot change the whole world at one time but I can surely start with one person at a time. I believe so much in the power of giving, whether knowledge, time or resources So much that I started my own foundation: the Open Hands Foundation.”

According to Dr Tsilo, her journey to graduating was intimidating – having to adjust to being a student was already tough, however adjusting to being a medical student proved to be a whole new level of challenging. It came with a lot of late nights and very early mornings, months without seeing her family and having almost no luxurious pastimes. 

But she persevered because she always had a goal and was determined to reach it. She had a vision to complete this degree and do it in record time and that’s exactly what she did. “Your vision should always fuel your mission,” says Dr Tsilo. 

Besides medicine, her other passions include charity work – something she has been doing right through her student years. 

Passion for charity work 

“I love charity work and if you did not find me studying, that’s what you would find me, doing. Open Hands is where I exercise this passion. I collect clothes, shoes and food items for the less privileged in our communities.
To students struggling and also facing difficulties, I have this simple message: Don’t stop. Don’t stop working hard, don’t stop hoping and dreaming and if you need help of any kind, it is always available. Know that you are not struggling alone, struggle is part of the journey – it always seems impossible but as long as you don’t stop you will eventually reach your destination.”

Prof Lynette van der Merwe, who took up her new position as Academic Head in the Division Health Sciences Education, Faculty of Health Sciences on 1 December 2021, congratulated the new cohort of UFS doctors and reminded them of the three Cs in the MBChB programme in 2021 – courage, conviction and compassion. She also proposed a new “C” for the year ahead: Character.  

“Character is seen in how you treat those who can do nothing for you. It takes time to develop, and only grows through suffering and failing; no shortcuts, no life hacks here. Character makes you seek to be worth knowing, rather than well known. Adam Grant says: ‘Meaning is about making a difference, not having an audience. Your legacy is not how many footprints you leave.  It’s how long they last.’ Wherever life takes you from here, whatever happens to you or through you, do what is right, not easy. Be a person of value, not success.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept